These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19005759)

  • 1. Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; Sagrado MG; Conde R; Velasco MC; Alvarez T; Pacheco D; González JM
    Dig Dis Sci; 2009 Aug; 54(8):1772-7. PubMed ID: 19005759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease.
    Aller R; De Luis DA; Izaola O; González Sagrado M; Conde R; Pacheco D; Velasco MC; Ovalle HF
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):335-41. PubMed ID: 22530350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.
    Aller R; de Luis DA; Fernandez L; Calle F; Velayos B; Olcoz JL; Izaola O; Sagrado MG; Conde R; Gonzalez JM
    Dig Dis Sci; 2008 Apr; 53(4):1088-92. PubMed ID: 17934820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.
    Gaddipati R; Sasikala M; Padaki N; Mukherjee RM; Sekaran A; Jayaraj-Mansard M; Rabella P; Rao-Guduru V; Reddy-Duvvuru N
    Ann Hepatol; 2010; 9(3):266-70. PubMed ID: 20720266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease.
    Aller R; Castrillon JL; de Luis DA; Conde R; Izaola O; Sagrado MG; Velasco MC; Alvarez T; Pacheco D
    Ann Hepatol; 2011; 10(1):50-5. PubMed ID: 21301010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome.
    Trakada G; Steiropoulos P; Nena E; Gkioka T; Kouliatsis G; Pataka A; Sotiriou I; Anevlavis S; Papanas N; Bouros D
    Sleep Breath; 2009 Nov; 13(4):349-55. PubMed ID: 19360446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
    Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
    Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of visfatin levels with insulin resistance and left ventricular hypertrophy in peritoneal dialysis patients.
    Karakan S; Sezer S; Özdemir Acar FN; Haberal M
    Ren Fail; 2012; 34(6):732-7. PubMed ID: 22503095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of visfatin in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P; Semik-Grabarczyk E; Holecki M; Dabrowski P; Skorupa A
    Metabolism; 2007 Aug; 56(8):1131-4. PubMed ID: 17618961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of olmesartan vs irbesartan on metabolic parameters and visfatin in hypertensive obese women.
    De Luis DA; Conde R; Gonzalez Sagrado M; Aller R; Izaola O; Perez Castrillon JL; Romero E; Castro MJ
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):759-63. PubMed ID: 21061834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS.
    Boemeke L; Raimundo FV; Bopp M; Leonhardt LR; Fernandes SA; Marroni CA
    Arq Gastroenterol; 2019; 56(1):28-33. PubMed ID: 31141077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
    Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
    Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
    Chen L; Liu W; Lai S; Li Y; Wang X; Zhang H
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):935-41. PubMed ID: 23470357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.